DARE - Dare Bioscience - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DARE is currently covered by 2 analysts with an average price target of $6.39. This is a potential upside of $4.27 (201.42%) from yesterday's end of day stock price of $2.12.

Dare Bioscience's activity chart (see below) currently has 9 price targets and 19 ratings on display. The stock rating distribution of DARE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 251 days.

Highest price target for DARE is $12, Lowest price target is $8, average price target is $10.

Most recent stock forecast was given by CAROLINE PALOMEQUE from BERENBERG on 03-Sep-2025. First documented stock forecast 17-Aug-2016.

Currently out of the existing stock ratings of DARE, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$8

$5.88 (277.36%)

1 months 9 days ago
(03-Sep-2025)

1/2 (50%)

$5.87 (275.59%)

660

Buy

$12

$9.88 (466.04%)

$12

6 months 12 days ago
(31-Mar-2025)

0/5 (0%)

$9.1 (313.79%)

Buy

$13

$10.88 (513.21%)

1 years 1 months 27 days ago
(15-Aug-2024)

0/1 (0%)

$9.43 (264.15%)

Buy

$3

$0.09 (3.09%)

1 years 4 months 28 days ago
(15-May-2024)

2/2 (100%)

$-1.32 (-30.56%)

135

Buy

$2

$-0.12 (-5.66%)

2 years 1 months 13 days ago
(29-Aug-2023)

1/1 (100%)

$-6.52 (-76.53%)

709

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DARE (Dare Bioscience) average time for price targets to be met?

On average it took 251 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on DARE (Dare Bioscience) with a proven track record?

KEMP DOLLIVER

Which analyst has the current lower performing score on DARE (Dare Bioscience) with a proven track record?

DEBJIT CHATTOPADHYAY

Which analyst has the most public recommendations on DARE (Dare Bioscience)?

Kemp Dolliver works at BROOKLINE and has 1 price targets and 2 ratings on DARE

Which analyst is the currently most bullish on DARE (Dare Bioscience)?

Debjit Chattopadhyay with highest potential upside - $69.88

Which analyst is the currently most reserved on DARE (Dare Bioscience)?

Jason Kolbert with lowest potential downside - -$0.12

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?